Trials / Completed
CompletedNCT04366024
A Novel Nomogram to Predict Severity of COVID-19
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (actual)
- Sponsor
- Xinqiao Hospital of Chongqing · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Investigators use clinical data from a large sample of COVID-19 disease patients to screen out biomarkers associated with disease severity. Then, a novel nomogram model will be established to predict covid-19 disease severity, which could provide important assistance and supplement for clinical work. In the case of extremely shortage of front-line medical resources, patients with potential severe diseases will be timely treated with the help of the novel nomogram model.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | other | clinical diagnosis |
Timeline
- Start date
- 2020-01-17
- Primary completion
- 2020-08-30
- Completion
- 2021-12-31
- First posted
- 2020-04-28
- Last updated
- 2024-02-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04366024. Inclusion in this directory is not an endorsement.